Nikhil Munshi

Nikhil C. Munshi, MD is the Kraft Family Chair and Professor of Medicine at the Harvard Medical School and the Director of Basic and Correlative Science, at the

Jerome Lipper Myeloma Center at the Dana Farber Cancer Institute. He is a senior physician at the Brigham and Women’s Hospital, Harvard Medical School. Professor Munshi studied medicine at the S.S.G. Hospital and M.S. University, in Baroda, India, before completing fellowships in oncology at the Johns Hopkins Oncology Center, Baltimore, MD, USA, and the Indiana University Medical Center, Indianapolis, IN, USA.

Dr. Munshi’s research focus spans both basic sciences to understand genomic changes in myeloma and elucidate molecular mechanisms driving the genomic instability in cancer, to translational approaches directed at improving diagnosis and prognosis as well as therapeutics. Dr Munshi’s clinical interests include CAR T-cell therapy in multiple myeloma and developing novel targeted therapeutics including novel antigen-directed and immune effector cell therapy/vaccine approaches.

He has over 500 peer-reviewed publications and book chapters. Dr Munshi has mentored over 70 junior faculty, post-doctoral fellows, medical residents. A number of them are now independent scientists, physicians, and professionals. He is the immediate former President of the International Myeloma Society. He has received number of Awards including the Dr. B.C. Roy National Award by the president of India in 2016, the prestigious “Waldenstrom’s Award” for Most Distinguished Lifetime Achievement in Myeloma Research in 2013, the COMy “Multiple Myeloma Excellence Award for Translational Research” in 2019 and Robert Kyle Award in 2021.